New Product: ReproCardio 2 (human iPSC-derived cardiomyocytes, frozen)
ReproCELL launches its second iPSC-cardiomyocyte product ReproCardio 2.
Since the world’s first launch of the first version product (ReproCardio), ReproCELL has been continuously improving the products and now established frozen cells as a product. ReproCardio 2 contains natural population of human heart cells which are necessary for efficient prediction of compound effects in the drug development process.
Please visit ReproCardio 2 product website to learn about it.